Your English writing platform
Discover LudwigSuggestions(1)
Exact(2)
Each of the inhibitors only partially utilizes the binding envelope.
Compound 53 (small-molecule ID NEE) has a distinct binding mode with the 4-chloro-3,5-dimethylphenoxybenzyl moiety extending into the hydrophobic pocket between the BC-loop and the N-terminus of the I-helix, constituting the short arm of the Y-shape inhibitor binding envelope.
Similar(58)
DrugSite [24] and PocketFinder [25] evaluate shape and physicochemical properties for identification of ligand binding envelopes.
A legally binding "noise envelope".
We found that the recombinant library IgGs were much weaker than the serum IgGs in binding to envelope glycoproteins (Envs) and in neutralizing the virus and inhibiting Env-mediated cell cell fusion.
In vitro, binding HIV envelope protein to CXCR4 has been shown to induce apoptosis of neoplastic breast cells.
Upon the binding of envelope protein gp120, CD4 receptor physically associates with either CXCR4 or CCR5 receptors to initiate the formation of the HIV entry complex [11], [12].
We used Autodock 4.0 molecular docking program [5], [6], which is widely used to identify a ligand binding contiguous envelope of maximum affinity for a given macromolecular structure.
In these cell types, HIV-1 entry is mediated by the binding of envelope glycoproteins (gp120 and gp41, Env) to the receptor CD4 and a coreceptor, principally CCR5 or CXCR4, depending on the viral strain (R5 or X4, respectively).
Whatever the cell type, HIV-1 entry is mediated by the binding of envelope glycoproteins (gp120 and gp41, Env) to the receptor CD4 and a coreceptor, principally CCR5 or CXCR4.
Human immunodeficiency virus (HIV) entry into cells is initiated by the binding of its envelope glycoprotein (Env) gp120 to receptor CD4.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com